Last reviewed · How we verify

NCT04981171

Electro-thumbtack Needle Therapy for Chronic Neck Pain

Status unknown NA Last updated 31 March 2022
What this trial tests

NA trial testing Electro-thumbtack Needle Therapy in Neck Pain in 180 participants. Status unknown.

Timeline
3 April 2022
Primary endpoint
31 December 2023
31 December 2023

Quick facts

Lead sponsorShi Hangyu
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment180
Start date3 April 2022
Primary completion31 December 2023
Estimated completion31 December 2023

Drugs / interventions tested

Conditions studied

Sponsor

Shi Hangyu

Who can join

Adults 18 to 65, any sex, with Neck Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective trial will be a single-center, participant-blinded, randomized controlled trial. It is reported in previous studies that both acupuncture and transcutaneous electrical nerve stimulation are effective in reducing neck pain comparing to placebo or exercise. Taking into account the convenience of electro-thumbtack needle therapy shown in clinical practice, this study aims to evaluate the efficacy and safety of electro-thumbtack needle therapy for alleviating chronic neck pain compared with sham electro-thumbtack needle therapy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy and Safety of Electro-Thumbtack Needle Therapy for Patients With Chronic Neck Pain: Protocol for a Randomized, Sham-Controlled Trial.
    Shi H, Wang X, Yan Y, Zhu L, et al · · 2022 · cited 2× · PMID 35572961 · DOI 10.3389/fmed.2022.872362

Verify or expand the search:

Other recruiting trials for Neck Pain

Currently open trials in the same condition.

Other Shi Hangyu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04981171.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing